About This Webinar   As advanced therapy pipelines grow, manufacturing capacity has become a critical constraint. Sponsors must secure CDMO partners with scalable GMP infrastructure capable of supporting clinical trials and commercial launch. This webinar provides an update on Minaris Advanced Therapies’ expanded capacity across cell and gene therapy manufacturing. The session highlights viral vector production, … Continued